Journal
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Volume 45, Issue 3, Pages 329-340Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PAS.0000000000001597
Keywords
meningioma; gene fusion; pediatric; YAP1; FAM118B; transcriptomics
Funding
- Nationwide Foundation Pediatric Innovation Fund
Ask authors/readers for more resources
Meningiomas, a type of central nervous system tumor, can be associated with the NF2 gene mutation. However, YAP1 fusion meningiomas have been found to exhibit distinct genetic and biological characteristics compared to NF2-driven meningiomas. Both types of meningiomas show overexpression of EGFR and MET, but YAP1 fusion meningiomas have unique histopathological features and a different DNA methylation profile.
Meningiomas are a central nervous system tumor primarily afflicting adults, with NF2 may be found in similar to 50% of meningiomas, with other genetic drivers (eg, SMO, AKT1, TRAF7) contributing to NF2 wild-type tumors. NF2 is an upstream negative regulator of YAP signaling and loss of the NF2 protein product, Merlin, results in YAP overexpression and target gene transcription. This mechanism of dysregulation is described in NF2-driven meningiomas, but further work is necessary to understand the NF2-independent mechanism of tumorigenesis. Amid our institutional patient-centric comprehensive molecular profiling study, we identified an individual with meningioma harboring a YAP1-FAM118B fusion, previously reported only in supratentorial ependymoma. The tumor histopathology was remarkable, characterized by prominent islands of calcifying fibrous nodules within an overall collagen-rich matrix. To gain insight into this finding, we subsequently evaluated the genetic landscape of 11 additional pediatric and adolescent/young adulthood meningioma patients within the Children's Brain Tumor Tissue Consortium. A second individual harboring a YAP1-FAM118B gene fusion was identified within this database. Transcriptomic profiling suggested that YAP1-fusion meningiomas are biologically distinct from NF2-driven meningiomas. Similar to other meningiomas, however, YAP1-fusion meningiomas demonstrated overexpression of EGFR and MET. DNA methylation profiling further distinguished YAP1-fusion meningiomas from those observed in ependymomas. In summary, we expand the genetic spectrum of somatic alteration associated with NF2 wild-type meningioma to include the YAP1-FAM118B fusion and provide support for aberrant signaling pathways potentially targetable by therapeutic intervention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available